Former UNAIDS executive director discusses progress in AIDS fight ahead of AIDS 2012 conference

The 2012 International AIDS Conference, which will take place in Washington, D.C., from July 22-27, "will highlight a sense of optimism among top HIV researchers about stemming the spread of the virus around the globe," according to PRI's "The World." In an audio report, anchor Lisa Mullins "talks to Peter Piot, former executive director of UNAIDS, about the new optimism and his career as a virus hunter."

"There's no doubt that we've made enormous progress in the fight against AIDS," Piot says in the report, and discusses some of these advancements. "But AIDS is not over by any means, and we should be realistic and think that we are in this for the long haul, for several decades," he adds, noting, "We still have well over 30 million people living with HIV somewhere in the world, and all of them, for decades, will need treatment," according to PRI (7/9).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Engineered virus-like particles evolve for superior gene delivery efficiency